Company News
Mankind Pharma Investor Presentation Outlines Growth Strategy
Mankind Pharma reported FY26 revenue of ₹14,278 Cr with an 18.1% CAGR from FY21–26, highlighting strong market position.
The company announced strategic acquisition of Armed Cell Therapeutics to enter
